This is the first episodes of a new series hosted by expert dermatologist Dr. Christopher Bunick who will be discussing the evolving role of JAK inhibitor therapies in the management of atopic dermatitis (AD). This episode, "The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors", featuring expert dermatologist Dr. John Koo, discusses the following topics:

• Understanding atopic dermatitis as a spectrum disorder, phenotypes and endotypes, and heterogeneity of atopic disease
• Summarizing JAK inhibitor therapies, including clinical safety and efficacy and mechanism of action
• Comparison of JAKi to biologics and traditional systemic agents, and the evolving role of JAKi in treatment of AD

LiVDerm.org